[A case of multiple pulmonary metastases from duodenal cancer showing partial response using 5'-DFUR and a small dose of MMC].

Author: ArakiH, HashimotoT, KodamaM, YasuiK, YoshiokaT

Paper Details 
Original Abstract of the Article :
A 77-year-old female with primary duodenal cancer had undergone pancreatoduodenectomy in May, 1989. Postoperative chemotherapy was done in combination with MMC (mitomycin C), lentinan and UFT (combined medicine of tegafur and uracil). In August, 1991, the patient complained of a cough and then was e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1361121

データ提供:米国国立医学図書館(NLM)

A Case of Multiple Pulmonary Metastases: A New Treatment Strategy?

The field of [oncology] is constantly seeking better ways to manage [cancer] and its spread. This case study explores a novel treatment approach for [multiple pulmonary metastases] from [duodenal cancer] using a combination of [5'-DFUR] and [MMC]. The study highlights the potential benefits of this combination therapy in achieving [partial response] for this challenging condition.

5'-DFUR and MMC: A Potential Breakthrough for Pulmonary Metastases

This case study provides a glimmer of hope for patients facing [multiple pulmonary metastases] from [duodenal cancer]. The successful use of [5'-DFUR] and [MMC] in achieving [partial response] suggests that this combination therapy could offer a valuable treatment option for this complex condition. While further research is needed to confirm its effectiveness and safety, this case study highlights the potential of this approach for managing this challenging form of cancer.

Understanding Cancer Treatment: A Collaborative Approach

This case study emphasizes the importance of a collaborative approach to [cancer] treatment. It demonstrates the potential benefits of seeking multiple perspectives and exploring innovative treatment options to find the best approach for individual patients. Open communication between patients and healthcare providers is crucial for ensuring that patients are informed about their treatment options and are involved in decision-making process.

Dr.Camel's Conclusion

This case study is like a lone traveler discovering a hidden oasis in the vast desert of cancer research. The success of [5'-DFUR] and [MMC] in treating [multiple pulmonary metastases] provides a promising new path for those facing this challenging diagnosis. While further research is needed, it reminds us to remain hopeful and to continually explore new treatment strategies to help those battling cancer.

Date :
  1. Date Completed 1993-01-08
  2. Date Revised 2015-11-23
Further Info :

Pubmed ID

1361121

DOI: Digital Object Identifier

1361121

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.